How Medicare Drug Plans Hope To Follow Private Sector Lead
The proposal that Medicare made this month to better control prescription drug costs involves testing strategies used with some success in the private sector.
Drugs
1,301-1,320 of 1,325 results
-
-
N.H., Calif. Seek To Help Consumers Get Details On Health Care Prices
New Hampshire is expanding its website that lists the cost of specific medical procedures to include dental treatments and 65 prescription drugs. California is expanding its report cards on large medical groups to include cost of medical services by an average patient.
By Jordan Rau -
Medicare To Test New Payment Approaches For Some Prescription Medications
Regulators unveiled a two-part plan that will change payments and test ways in which the Medicare Part B program can change the incentives that some policy experts say encourage doctors to choose higher-cost medications.
-
Candidates’ Drug-Price Plans May Miss The Mark
There is more than one reason prices are rising, and no single solution.
By Julie Rovner -
Urban Medicare Beneficiaries May See More Drug Savings This Year
The Centers for Medicare & Medicaid Services says access to special, lower-cost pharmacies has improved for Medicare beneficiaries in urban areas.
-
Are States Obligated To Provide Expensive Hepatitis C Drugs?
New hepatitis C drugs boast cure rates of at least 95 percent. But states are restricting their use for Medicaid patients and prisoners because the cost is so high.
-
Study: Doctors’ Texts Can Prod Patients To Take Drugs, But Questions Linger
In an analysis published Monday in JAMA Internal Medicine, researchers found that text message reminders help patients do better when it comes to taking their medicines. But questions about the specific ways to make the most of this strategy remain.
-
California Voters Will Have Their Say On Drug Prices
Heated battle expected over November ballot proposal to curb state’s prescription drug costs, as pharmaceutical industry opens its pocketbook to defeat the measure.
By Anna Gorman -
Want Into A Clinical Trial? Read This First.
Experimental drugs might help desperate patients, but don’t count on an easy cure.
By Emily Bazar -
Research Gives Context To Addressing Nation’s Drug Abuse Crisis, Review Finds
As presidential candidates, state officials and even President Barack Obama wrestle with how to handle drug addiction, scientists lay out some of the intersections between opioid prescriptions and heroin abuse in the New England Journal of Medicine, including findings that crackdowns on opioid prescriptions may not fuel increases in heroin use.
-
Health Plans’ Coverage Of Some Drugs Can Be A Source Of Consumer Confusion
Some medicines, particularly intravenous treatments, are not listed in plans’ pharmacy benefit section and, therefore, it’s difficult to confirm coverage specifics.
-
Broader Strategies Necessary To Counter Painkiller Over Prescribing, Researchers Say
A research letter published Monday in JAMA Internal Medicine says opioid-prescribing practices are consistent with that of other medications.
-
Testing For Hepatitis C In Prisons Could Save Many Lives On The Outside
Treating Hep C is expensive, but new drugs can quickly cure the disease, ultimately saving money.
-
Most Americans See Personal Tie To Rising Prescription Painkiller Abuse
A new Kaiser Family Foundation tracking poll reports 16 percent say they know someone who died from a prescription painkiller overdose.
-
Fewer Medicare-Subsidized Drug Plans Means Less Choice For Low-Income Seniors
The number of Medicare plans that cover medications with a subsidy provided for low-income beneficiaries is declining in 2016 by 20 percent.
By Susan Jaffe -
Cancer Meds Often Bring Big Out-Of-Pocket Costs For Patients, Report Finds
The advocacy arm of the American Cancer Society said Wednesday that federal and state governments should move to restrict insurers from charging patients a percentage of the cost of their prescription drugs.
-
Study Finds Marketplace Silver Plans Offer Poor Access To HIV Drugs
Only 16 percent of the popular plans cover all 10 of the most common drug regimens and charge less than $100 a month in consumer cost sharing, according to a report by Avalere Health.
-
‘Do The Math’ When Shopping For A Health Plan This Open Enrollment Season
Because of the complexity of insurance available through healthcare.gov and state exchanges, and the broad variation in how prescription drugs are covered, experts encourage consumers to compare options to figure out which one best fits their needs.
-
Poll: Majority Of Americans Agree That The FDA Should Review Drug Ads Before They Air
Nearly eight in 10 say they have seen or heard these ads, and more than a quarter have discussed one of the drugs with a physician as a result.
-
Seniors Who Don’t Consider Switching Drug Plans May Face Steep Price Rise
For beneficiaries, staying in their current plans could prove costly so advocates urge them to check out the alternatives.